Stockscreener 앱 받기
426.09
0.64%
2.71
시간 외 거래:
426.80
0.71
+0.17%
전일 마감가:
$423.38
열려 있는:
$426.72
하루 거래량:
9.94M
Relative Volume:
1.39
시가총액:
$386.95B
수익:
$449.71B
순이익/손실:
$12.81B
주가수익비율:
32.18
EPS:
13.2409
순현금흐름:
$19.67B
1주 성능:
+0.35%
1개월 성능:
+6.65%
6개월 성능:
+28.72%
1년 성능:
+47.91%
1일 변동 폭
$425.10
$437.47
1주일 범위
$414.37
$461.62
52주 변동 폭
$234.60
$461.62
유나이티드헬스 그룹 Stock (UNH) Company Profile
명칭
Unitedhealth Group Inc
전화
1-800-328-5979
주소
1 HEALTH DRIVE, EDEN PRAIRIE
Compare UNH vs CVS, ELV, CI, HUM
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
UNH
Unitedhealth Group Inc
|
426.09 | 384.49B | 449.71B | 12.81B | 19.67B | 13.24 |
CVS
Cvs Health Corp
|
107.47 | 135.89B | 407.94B | 2.90B | 7.39B | 2.2771 |
ELV
Elevance Health Inc
|
373.11 | 80.86B | 200.42B | 5.24B | 6.45B | 23.50 |
CI
Cigna Group
|
281.45 | 75.08B | 278.13B | 6.74B | 7.66B | 23.60 |
HUM
Humana Inc
|
400.00 | 46.40B | 137.20B | 1.15B | 1.27B | 9.3439 |
유나이티드헬스 그룹 Stock (UNH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-06-04 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2026-04-27 | 업그레이드 | Erste Group | Hold → Buy |
| 2026-04-22 | 업그레이드 | Argus | Hold → Buy |
| 2026-04-07 | 업그레이드 | HSBC Securities | Reduce → Hold |
| 2026-04-01 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2025-10-29 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2025-10-14 | 개시 | Goldman | Buy |
| 2025-07-31 | 다운그레이드 | Robert W. Baird | Neutral → Underperform |
| 2025-07-30 | 재확인 | Oppenheimer | Outperform |
| 2025-06-11 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2025-05-21 | 다운그레이드 | HSBC Securities | Hold → Reduce |
| 2025-05-19 | 다운그레이드 | TD Cowen | Buy → Hold |
| 2025-05-14 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2025-05-14 | 다운그레이드 | Raymond James | Strong Buy → Mkt Perform |
| 2025-04-22 | 다운그레이드 | HSBC Securities | Buy → Hold |
| 2025-04-21 | 다운그레이드 | Argus | Buy → Hold |
| 2025-01-10 | 업그레이드 | HSBC Securities | Hold → Buy |
| 2025-01-06 | 재확인 | Truist | Buy |
| 2024-10-17 | 다운그레이드 | HSBC Securities | Buy → Hold |
| 2024-10-11 | 개시 | KeyBanc Capital Markets | Overweight |
| 2024-07-17 | 업그레이드 | Jefferies | Hold → Buy |
| 2024-07-17 | 재확인 | RBC Capital Mkts | Outperform |
| 2024-06-05 | 업그레이드 | HSBC Securities | Hold → Buy |
| 2024-05-30 | 개시 | Robert W. Baird | Outperform |
| 2024-04-04 | 업그레이드 | HSBC Securities | Reduce → Hold |
| 2024-03-06 | 개시 | Barclays | Overweight |
| 2023-12-18 | 다운그레이드 | HSBC Securities | Hold → Reduce |
| 2023-10-16 | 업그레이드 | UBS | Neutral → Buy |
| 2023-09-06 | 개시 | HSBC Securities | Hold |
| 2023-07-19 | 재확인 | UBS | Neutral |
| 2023-07-18 | 업그레이드 | Bernstein | Mkt Perform → Outperform |
| 2023-07-17 | 재확인 | JP Morgan | Overweight |
| 2023-07-17 | 재확인 | RBC Capital Mkts | Outperform |
| 2023-07-17 | 재확인 | TD Cowen | Outperform |
| 2023-05-26 | 개시 | Piper Sandler | Overweight |
| 2023-04-21 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-04-05 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2022-11-23 | 재개 | Morgan Stanley | Overweight |
| 2022-11-21 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2022-06-17 | 개시 | Loop Capital | Buy |
| 2022-05-27 | 다운그레이드 | Bernstein | Outperform → Mkt Perform |
| 2021-12-14 | 개시 | Goldman | Buy |
| 2021-09-27 | 개시 | SVB Leerink | Outperform |
| 2021-09-10 | 개시 | Cowen | Outperform |
| 2021-07-09 | 개시 | Seaport Global Securities | Buy |
| 2021-06-01 | 재확인 | BofA Securities | Buy |
| 2021-05-19 | 개시 | Wells Fargo | Overweight |
| 2021-04-21 | 업그레이드 | Argus | Hold → Buy |
| 2020-10-19 | 다운그레이드 | Argus | Buy → Hold |
| 2020-07-01 | 재개 | SVB Leerink | Outperform |
| 2020-06-05 | 개시 | Goldman | Buy |
| 2020-03-20 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2019-10-18 | 개시 | Mizuho | Buy |
| 2019-10-10 | 다운그레이드 | Jefferies | Buy → Hold |
| 2019-09-30 | 다운그레이드 | BMO Capital Markets | Outperform → Market Perform |
| 2019-09-12 | 개시 | Deutsche Bank | Hold |
| 2019-05-10 | 업그레이드 | Citigroup | Neutral → Buy |
| 2019-04-23 | 개시 | UBS | Neutral |
| 2019-04-17 | 재확인 | BofA/Merrill | Buy |
| 2019-01-14 | 개시 | Stephens | Overweight |
| 2018-09-10 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2018-06-11 | 개시 | SunTrust | Buy |
| 2018-03-08 | 개시 | Barclays | Overweight |
| 2018-01-17 | 재확인 | Citigroup | Buy |
| 2018-01-12 | 재확인 | Evercore ISI | Outperform |
| 2018-01-03 | 개시 | Goldman | Buy |
| 2017-07-19 | 재확인 | Mizuho | Buy |
| 2017-06-07 | 개시 | Morgan Stanley | Overweight |
모두보기
유나이티드헬스 그룹 주식(UNH)의 최신 뉴스
UnitedHealth says aggressive billing, pharmacy drugs drove medical costs up in Q2 - HR Brew
UNH Maintained by Oppenheimer -- Price Target Raised to $500 - GuruFocus
UnitedHealthcare exec says 'ineffective' No Surprises Act IDR process demands reform - Fierce Healthcare
UNH Maintained by Morgan Stanley -- Price Target Raised to $529 - GuruFocus
UNH Maintained by Keybanc -- Price Target Raised to $500 - GuruFocus
UNH Maintained by UBS -- Price Target Raised to $490 - GuruFocus
Dow Holds Steady While Nasdaq Stumbles: What Moved Markets This Week - The Motley Fool
Leerink Partners Adjusts UnitedHealth Group Price Target to $472 From $462 - marketscreener.com
UnitedHealth Poised for Further Growth Despite Employer Commercial Pressure, RBC Says - marketscreener.com
UBS raises UnitedHealth stock price target to $490 on MA strength - Investing.com
UBS Adjusts Price Target on UnitedHealth to $490 From $460, Maintains Buy Rating - marketscreener.com
UnitedHealth (UNH) Beat Q2 EPS by 30% and the Medical Cost Ratio Hit a Two-Year Low; Is $454 the Target? - TradingKey
Why UnitedHealth Can't Stop Saying One Word: 'Restless' - Benzinga
UnitedHealth Q2 Earnings Call Focuses on Reset and Durable Growth - Yahoo Finance
UnitedHealth Analysts Increase Their Forecasts After Better-Than-Expected Q2 Results - Benzinga
Oppenheimer Adjusts Price Target on UnitedHealth to $500 From $420, Maintains Outperform Rating - marketscreener.com
UnitedHealth Group (UNH) Raised Guidance, Is The Stock Still Cheap? - simplywall.st
Deutsche Bank Raises UnitedHealth Group Price Target to $467 From $370, Maintains Hold Rating - marketscreener.com
RBC Capital Adjusts UnitedHealth Price Target to $478 From $463, Maintains Outperform Rating - marketscreener.com
Morgan Stanley Adjusts Price Target on UnitedHealth to $529 From $468, Maintains Overweight Rating - marketscreener.com
UnitedHealth: Turnaround Is Progressing Even Better Than I Thought (Earnings Review) - Seeking Alpha
UnitedHealth Group Incorporated Stock 12‑Month Price Target Raised to $471.8, Implies 11% Upside - TradingView
Barclays Adjusts Price Target on UnitedHealth to $441 From $429, Maintains Overweight Rating - marketscreener.com
Goldman Sachs Adjusts Price Target on UnitedHealth to $490 From $435, Maintains Buy Rating - marketscreener.com
Financiere des Professionnels Fonds d investissement inc. Purchases 9,755 Shares of UnitedHealth Group Incorporated $UNH - InsuranceNewsNet
Full Transcript: UnitedHealth Group Q2 2026 Earnings Call - Sahm
What’s Fueling UNH Stock’s Rally? A Bigger Buyback, Higher Guidance – And CEO Says Turnaround Is ‘Returning To Form’ - TradingView
UnitedHealth Group Stock Rises 37% Year-to-Date, Market Sees Path Back to All-Time Highs - NAI500
UnitedHealth Says AI Now Runs Every Function of Its Business - PYMNTS.com
UnitedHealth (UNH) Q2 2026 Earnings Call Transcript - The Motley Fool
How to Earn $500 a Month From UnitedHealth Stock Ahead of Q2 Earnings - Yahoo Finance
UnitedHealth Surged 10% Intraday After Earnings. Here’s Where UNH Stock Could Head in 2026 - TIKR.com
UnitedHealth Shatters Estimates as AI Trims Medical Costs by 270 Basis Points - Tech Times
Has UnitedHealth Group Hit Rock Bottom, Or Is More Pain Ahead - Kavout | AI
UnitedHealth Group Incorporated Stock 12‑Month Price Target Raised to $451.24, Implies 8% Upside - TradingView
Why UnitedHealth (UNH) Stock Is Trading Up Today - Yahoo Finance
UnitedHealth Group Q2: The Real Test Begins Now (Downgrade) (NYSE:UNH) - Seeking Alpha
UnitedHealth Jumps 10.3% After Raising 2026 EPS Outlook Above Estimates - TradingView
Where UnitedHealth says its AI investments are paying off - Digital Insurance
UnitedHealth Jumps 10.3% After Raising 2026 EPS Outlook Above Es - GuruFocus
UnitedHealth Stock Hits 2026 High on Strong Earnings, Rosy Outlook - Investopedia
UnitedHealth employer plan costs driven by No Surprises Act system - BenefitsPRO
UnitedHealth Group Inc (UNH) Q2 2026 Earnings Call Highlights: S - GuruFocus
UNH Upgraded by Baird -- Price Target Raised to $453 - GuruFocus
UnitedHealth Group Reports Strong Q2 2026 Results Amid Cost Pressures - HCI Innovation Group
Market movers: AtaiBeckley, UnitedHealth Group, Abbott Laboratories, Medicus Pharma… - Proactive financial news
UnitedHealth Group Inc (UNH) Q2 2026 Earnings Call Highlights: Strong EPS Growth Amidst Cost ... By GuruFocus - Investing.com Canada
UnitedHealth (UNH) Reports Strong Q2 Earnings and Raises Outlook - GuruFocus
UnitedHealth (UNH) Receives Upgrade from Underperform to Neutral by Analyst - GuruFocus
Despite earnings celebration, UnitedHealth signals more financial pain for employers - STAT
UnitedHealth Group beats Q2 earnings estimates, raises 2026 EPS guidance, and plans aggressive buybacks. - Pluang
유나이티드헬스 그룹 (UNH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.91%
0.84%
자본화:
|
볼륨(24시간):